Structured Summary
Abstract
Works about comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
See Also
MeSH Record
Synonyms
6 entry terms
- Clinical Trials, Phase 3 as Topic
- Clinical Trials, Phase III as Topic
- Drug Evaluation, FDA Phase 3 as Topic
- Drug Evaluation, FDA Phase III as Topic
- Evaluation Studies, FDA Phase 3 as Topic
- Evaluation Studies, FDA Phase III as Topic
MeSH Record
Aspects Covered
11 allowable subheadings
Indexed with the subheadings classification, economics, ethics, history, instrumentation, legislation & jurisprudence, methods, psychology, standards, statistics & numerical data, veterinary.
MeSH Record
Indexing Annotation
for general design, methodology, economics, etc. of phase III clinical trials; a different heading CLINICAL TRIAL, PHASE III is used for reports of a specific phase III clinical trial
MeSH Record
History Note
2008(1993)
MeSH Record
Previous Indexing
- Clinical Trials (1980-1992)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Phase III as Topic Clinical Trials. Medical Subject Headings (MeSH). 2026. Unique ID D017326. http://id.nlm.nih.gov/mesh/2026/D017326
- Phase III as Topic Clinical Trials. In: Wikipedia. https://en.wikipedia.org/wiki/Phase_III_clinical_trial
- Phase III as Topic Clinical Trials. In: Wikidata. https://www.wikidata.org/wiki/Q42824827